share_log

Exane BNP Paribas Initiates Coverage On Stem With Neutral Rating, Announces Price Target of $5

Exane BNP Paribas Initiates Coverage On Stem With Neutral Rating, Announces Price Target of $5

Exane BNP Paribas以中性评级开始对Stem进行报道,宣布目标股价为5美元
Benzinga ·  2023/10/20 06:55

Exane BNP Paribas analyst Moses Sutton initiates coverage on Stem (NYSE:STEM) with a Neutral rating and announces Price Target of $5.

Exane BNP Paribas分析师摩西·萨顿以中性评级启动对Stem(NYSE:STEM)的报道,并宣布目标价为5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发